Cargando…
Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter"
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733312/ https://www.ncbi.nlm.nih.gov/pubmed/35000738 http://dx.doi.org/10.1016/j.jaip.2021.10.062 |
_version_ | 1784627776105480192 |
---|---|
author | Strauss, Ronald Attaway, Amy H. Zein, Joe G. |
author_facet | Strauss, Ronald Attaway, Amy H. Zein, Joe G. |
author_sort | Strauss, Ronald |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8733312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-87333122022-01-06 Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter" Strauss, Ronald Attaway, Amy H. Zein, Joe G. J Allergy Clin Immunol Pract Correspondence and Reply American Academy of Allergy, Asthma & Immunology 2022-01 2022-01-06 /pmc/articles/PMC8733312/ /pubmed/35000738 http://dx.doi.org/10.1016/j.jaip.2021.10.062 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence and Reply Strauss, Ronald Attaway, Amy H. Zein, Joe G. Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter" |
title | Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter" |
title_full | Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter" |
title_fullStr | Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter" |
title_full_unstemmed | Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter" |
title_short | Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter" |
title_sort | reply to "a limitation regarding the association between intranasal corticosteroid use and better covid-19 outcomes: nasal symptoms matter" |
topic | Correspondence and Reply |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733312/ https://www.ncbi.nlm.nih.gov/pubmed/35000738 http://dx.doi.org/10.1016/j.jaip.2021.10.062 |
work_keys_str_mv | AT straussronald replytoalimitationregardingtheassociationbetweenintranasalcorticosteroiduseandbettercovid19outcomesnasalsymptomsmatter AT attawayamyh replytoalimitationregardingtheassociationbetweenintranasalcorticosteroiduseandbettercovid19outcomesnasalsymptomsmatter AT zeinjoeg replytoalimitationregardingtheassociationbetweenintranasalcorticosteroiduseandbettercovid19outcomesnasalsymptomsmatter |